Physician profile
Mona Imam
NPI 1053351494
$1,211.04
in general payments reported to CMS, 2019-2025
17 companies · $47.58 in 2025
The $47.58 reported for 2025 was less than what a typical Allergy & Immunology provider received nationally (typical 2025 total: $1,138).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $112 · 2020: $266 · 2021: $238 · 2022: $396 · 2023: $136 · 2024: $15.16 · 2025: $47.58.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $199.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $199.02 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $279.61 | 2019-2022 | |
| Glaxosmithkline, LLC. | $272.91 | 2019-2024 | Trelegy Ellipta |
| Takeda Pharmaceuticals U.S.A., INC. | $216.17 | 2020-2023 | Cinryze |
| Amgen INC. | $69.13 | 2021-2022 | |
| Genentech USA, INC. | $51.55 | 2021-2025 | Xolair |
| Grifols USA, LLC | $49.99 | 2019-2023 | Xembify |
| Teva Pharmaceuticals USA, INC. | $48.04 | 2022 | |
| Abbvie INC. | $44.45 | 2022 | |
| Csl Behring | $42.88 | 2020-2021 | |
| Biocryst US Sales Co., LLC | $23.09 | 2021-2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $18.00 | 2019 | |
| Shire North American Group INC | $16.87 | 2019 | |
| Kaleo, INC. | $16.83 | 2021 | |
| Optinose US, INC. | $16.59 | 2025 | |
| Horizon Therapeutics Plc | $16.47 | 2022 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alk-Abello, INC | $14.64 | 2021 | |
| Genzyme Corporation | $13.82 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mona Imam listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.